← Leaderboards
Nicholas James Maness
Tulane University Of Louisiana
$2,261,000
Attributed
$2,261,000
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $467.5K · FY2015–24$500K$375K$250K$125K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$2,261,000 · 5
By mechanism
R21$2,086,000 · 4
R03$175,000 · 1
Top collaborators
No co-investigators on record.
Most similar at Tulane University Of Louisiana
Same institution · by research overlap
- John C. C. Beier$7,134,563
- Anil Mishra$7,502,077
- James E Robinson$7,547,091
- Elizabeth B Norton$7,814,261
Others in their field
Top investigators on “Animals”
- David Heimbrook · Leidos Biomedical Research, Inc.$534,904,829
- Richard Webby · St. Jude Children'S Research Hospital$259,408,394
- Eric S Lander · Whitehead Institute For Biomedical Res$209,574,154
- Dennis R. Burton · Scripps Research Institute$204,129,233
- Richard K. Wilson · Washington University$130,501,539
- Mark S Klempner · Tufts Medical Center$129,182,794
Research focus
AnimalsViralMacacaIn VitroInfectionVirusResponseCellsSiteT-LymphocyteFutureT Cell ResponsePreventPharmaceutical PreparationsImmuneCd8-Positive T-LymphocytesExhibitsImmune ResponseMacaca MulattaTranslatingEpitopesPublishingMediatingCovid-19 Pandemic
Grant awards (11)
Pan Coronavirus Genomic Surveillance of a Large NHP Colony$87,500
R03 · FY2024 · AI · contact PI
Pan Coronavirus Genomic Surveillance of a Large NHP Colony$87,500
R03 · FY2023 · AI · contact PI
T cell modulation of COVID-19 disease$218,750
R21 · FY2022 · AI · contact PI
T cell modulation of COVID-19 disease$212,500
R21 · FY2022 · AI · contact PI
T cell modulation of COVID-19 disease$255,000
R21 · FY2021 · AI · contact PI
Reservoir modulation by Nef and anti-nef CTL$212,500
R21 · FY2021 · AI · contact PI
Reservoir modulation by Nef and anti-nef CTL$255,000
R21 · FY2020 · AI · contact PI
Focused characterization of non-canonical T cells against SIV$212,500
R21 · FY2019 · AI · contact PI
Focused characterization of non-canonical T cells against SIV$255,000
R21 · FY2018 · AI · contact PI
SIV antisense epitopes as novel markers of latency$211,250
R21 · FY2016 · AI · contact PI
SIV antisense epitopes as novel markers of latency$253,500
R21 · FY2015 · AI · contact PI